Clinical Psychiatry News - Settlement on Zyprexa leaks
A former consultant to Eli Lilly & Co. has agreed to pay the drug maker $100,000 to settle complaints that he leaked confidential information about Zyprexa (olanzapine) to a plaintiffs’ attorney. Dr. David Egilman was an expert witness for the plaintiffs in Zyprexa product liability suits. Under the agreement, Dr.
Related Results
Injectable ZyprexaZyprexa WarningZyprexa filingZyprexa unveiledTexas depresses Zyprexa
Egilman acknowledged that he had intentionally and illegally given attorney James Gottstein documents that had been made available by Lilly during discovery, and that “he knew that these materials painted an incomplete picture of the issues related to Zyprexa,” according to a statement by Lilly. Mr. Gottstein shared the documents with the New York Times, which wrote a series of articles in December 2006 contending that Lilly had withheld information about side effects. Lilly said it would donate Dr. Egilman’s settlement to the International Center for Clubhouse Development.
COPYRIGHT 2007 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
